Sellas Life Sciences is trading at $13.13 (+4.04%) as the stock gains momentum following a volatile stretch and a move off its recent lows.
- The stock has moved significantly higher from its $12.62 close on July 13, indicating a strong technical rebound.
- No company-specific news, earnings, or regulatory catalysts were identified to account for the move.
- The price action appears to be driven by broader biotechnology sector positioning and general market volatility rather than fundamental headlines.